Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.
about
Hepatic circadian-clock system altered by insulin resistance, diabetes and insulin sensitizer in miceRole of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver diseaseNAD+ loss, a new player in AhR biology: prevention of thymus atrophy and hepatosteatosis by NAD+ repletion.Sirt1 and Sirt6 mediate beneficial effects of rosiglitazone on hepatic lipid accumulation.Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone densityCyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-The human sirtuin family: evolutionary divergences and functions.Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic ratsNeuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease.Reduced food intake is the major contributor to the protective effect of rimonabant on islet in established obesity-associated type 2 diabetesHepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.Chromatin and beyond: the multitasking roles for SIRT6The kielin/chordin-like protein KCP attenuates nonalcoholic fatty liver disease in mice.Role of peroxisome proliferator-activated receptor gamma agonist in improving hepatic steatosis: Possible molecular mechanismSirt6 alters adult hippocampal neurogenesis.Time course of the development of nonalcoholic Fatty liver disease in the Otsuka long-evans Tokushima Fatty rat.Update on pparγ and nonalcoholic Fatty liver disease.Circulating betatrophin is associated with insulin resistance in humans: cross-sectional and interventional studies in vivo and in vitro.The effects of chronic candesartan treatment on cardiac and hepatic adenosine monophosphate-activated protein kinase in rats submitted to surgical stress.Perinatal Inhibition of NF-KappaB Has Long-Term Antihypertensive and Renoprotective Effects in Fawn-Hooded Hypertensive Rats.Coadministration of alloxan and nicotinamide in rats produces biochemical changes in blood and pathological alterations comparable to the changes in type II diabetes mellitus.Natural polyphenols as sirtuin 6 modulators.The Role of Sirt6 in Obesity and Diabetes.Hepatocyte ALOXE3 is induced during adaptive fasting and enhances insulin sensitivity by activating hepatic PPARγ
P2860
Q27311473-2E4A3986-9D42-4B43-899D-706D5D05368FQ33607697-A9D087D1-CFA2-4560-A45F-41E85CA8B574Q33720228-8F82A691-8577-4F57-8538-8C01C3B8FB3CQ34061979-B120AE15-80D0-44DC-AD54-566B9BED6AC5Q34510930-7BF11EC7-8C2E-48BA-8727-F5FC8B02E2D2Q35351777-0271C607-B2D2-42F2-9057-2CDA5C57F61BQ35592289-6F4DAFB9-1645-4E1B-A89E-B257AFB66038Q35819533-039F28EF-7100-48D9-8429-4395FC00702FQ36813115-25A6A8E9-CE8E-4947-B83C-38B1FF33B36DQ37094682-E5EB5859-E8EB-4486-BCD4-249D8BDE3572Q37163041-3A11FBC3-62BB-4BFD-BD68-DD9F16124DCEQ37375539-91817C56-1BE4-4C03-A06B-260337949EC9Q37549637-531CF043-4FD6-47AC-ABE3-4AAFC6B04431Q39499177-35BB1EB4-019F-4DD1-8012-96C532C518ABQ39604886-1EAFEBDD-6682-467F-9A5D-408B46CF5F0CQ41057061-D9199448-FF18-43BC-9736-92726BAEB890Q41135882-E25FEE87-2D23-4982-84F6-158EC31894ABQ41903480-9D9C5BB5-ED3C-453F-BC84-741BDB6B10B6Q47108186-94015228-7299-42BA-A058-AB38F9537B55Q47768588-4EC17DEB-B9E1-481D-AD0E-4C165B00BEC5Q50587701-0DE844B6-89AA-4076-B2D8-7F04BB5F1E27Q51699602-A21A723A-E877-4C56-8DAF-4DA6375F7521Q51743284-C7C811A7-7041-460A-B4B8-1D915C018AF3Q51763383-DA4B9E26-1504-4C0B-B185-E9F9CD282FCEQ58710925-FC87CEEA-696E-4407-93AD-4175B4C7F518
P2860
Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activation of peroxisome proli ...... tes hepatic steatosis in rats.
@ast
Activation of peroxisome proli ...... tes hepatic steatosis in rats.
@en
type
label
Activation of peroxisome proli ...... tes hepatic steatosis in rats.
@ast
Activation of peroxisome proli ...... tes hepatic steatosis in rats.
@en
prefLabel
Activation of peroxisome proli ...... tes hepatic steatosis in rats.
@ast
Activation of peroxisome proli ...... tes hepatic steatosis in rats.
@en
P2093
P2860
P50
P1433
P1476
Activation of peroxisome proli ...... ates hepatic steatosis in rats
@en
P2093
Cheol-Young Park
Jung Mook Choi
Se Eun Park
Seoung Wan Chae
Sun Woo Kim
Sung Woo Park
Won Jun Kim
P2860
P304
P356
10.1371/JOURNAL.PONE.0017057
P407
P577
2011-02-23T00:00:00Z